Genentech, Kevin Sin: Harnessing the power of the body to fight cancer




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Genentech, Kevin Sin: Harnessing the power of the body to fight cancer
Released on: January 30, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this interview, filmed at BIO Europe in Vienna, Paul Larsmon talks to Kevin Sin, Director, Business Development, Oncology at Genentech about their collaborations with Immunocore for the discovery and development of multiple novel cancer targets using Immunocore’s ImmTAC technology and Constellation to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for cancer and other serious diseases.
  • Summary
  • Transcript
  • Participants
  • Company
In this interview, filmed at BIO Europe in Vienna, Paul Larsmon talks to Kevin Sin, Director, Business Development, Oncology at Genentech about their collaborations with Immunocore for the discovery and development of multiple novel cancer targets using Immunocore’s ImmTAC technology and Constellation to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for cancer and other serious diseases.
In this interview, filmed at BIO Europe in Vienna, Paul Larsmon talks to Kevin Sin, Director, Business Development, Oncology at Genentech about their collaborations with Immunocore for the discovery and development of multiple novel cancer targets using Immunocore’s ImmTAC technology and Constellation to launch a broad collaboration based on the science of epigenetics and chromatin biology to discover and develop innovative treatments for cancer and other serious diseases.
Kevin Sin
Genentech
Genentech
Genentech Inc., a portmanteau of Genetic Engineering Technology, Inc., is a biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer.